CHOSA Oncology
CHOSA Oncology AB initiates payment of last portion of loan given to RhoVac AB
REG
CEO Peter Buhl commenting: "After several administrative steps CHOSA has initiated the pay back process to fulfill our obligations towards the loan givers. I want to thank you all for your patience and for your support in developing products for hard-to-treat cancers."
This disclosure contains information that Chosa Oncology AB is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 08-04-2023 10:31 CET.
| Datum | 2023-04-08, kl 10:31 |
| Källa | Cision |
Vill du synas här? Kontakta hej@allaaktier.se. Vår sajt har 125 000 sidvisningar och 17 000 unika besökare per månad. Vår discord har 7800 medlemmar. Detta är aktiva sparare med ett stort aktieintresse. Behöver du nå ut till denna målgrupp så hör av dig!